Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.35789033196905.
The log-likelihood improved by 3.649.
Iteration 2 of at most 500:
Optimizing with step length 0.609495695859907.
The log-likelihood improved by 2.578.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 2.217.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.7075.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       19     1303     1096      748      380      366      340 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     256      199      133       83       39       21       10        3 
degree16 degree17 degree18 
       1        1        1 
1 
disease_progression 
H-positive risk:  848 880 126 910 471 129 828 438 131 56 121 62 
H-negative risk:  880 848 828 910 438 471 129 126 121 131 62 56 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
46 new agents 
2 
disease_progression 
H-positive risk:  845 889 126 911 467 130 828 437 130 55 121 61 
H-negative risk:  889 845 828 911 437 467 130 126 121 130 61 55 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
3 
disease_progression 
H-positive risk:  848 895 124 909 467 131 826 433 131 54 121 61 
H-negative risk:  895 848 826 909 433 467 131 124 121 131 61 54 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
49 new agents 
4 
disease_progression 
H-positive risk:  848 905 125 915 461 129 826 427 129 53 122 60 
H-negative risk:  905 848 826 915 427 461 129 125 122 129 60 53 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
75 new agents 
5 
disease_progression 
H-positive risk:  865 908 127 913 450 131 827 423 126 53 120 57 
H-negative risk:  908 865 827 913 423 450 131 127 120 126 57 53 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
47 new agents 
6 
disease_progression 
H-positive risk:  880 914 128 902 445 130 830 424 122 51 118 56 
H-negative risk:  914 880 830 902 424 445 130 128 118 122 56 51 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 7 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
7 
disease_progression 
H-positive risk:  881 916 131 903 440 132 830 423 123 51 114 56 
H-negative risk:  916 881 830 903 423 440 132 131 114 123 56 51 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
59 new agents 
8 
disease_progression 
H-positive risk:  889 921 130 906 439 132 822 418 124 50 113 56 
H-negative risk:  921 889 822 906 418 439 132 130 113 124 56 50 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 10 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
9 
disease_progression 
H-positive risk:  893 923 132 899 437 133 826 414 122 50 114 57 
H-negative risk:  923 893 826 899 414 437 133 132 114 122 57 50 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 12 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
10 
disease_progression 
H-positive risk:  895 925 134 896 431 135 833 411 123 48 115 54 
H-negative risk:  925 895 833 896 411 431 135 134 115 123 54 48 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 12 1 

clinical_engagement 
diagnosis 
demography 
59 new agents 
11 
disease_progression 
H-positive risk:  902 930 135 894 425 136 829 409 126 49 111 54 
H-negative risk:  930 902 829 894 409 425 136 135 111 126 54 49 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 14 1 

clinical_engagement 
diagnosis 
demography 
74 new agents 
12 
disease_progression 
H-positive risk:  912 933 139 899 418 135 823 403 126 49 110 53 
H-negative risk:  933 912 823 899 403 418 135 139 110 126 53 49 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
47 new agents 
13 
disease_progression 
H-positive risk:  827 854 129 976 418 126 916 390 136 48 126 54 
H-negative risk:  854 827 916 976 390 418 126 129 126 136 54 48 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 16 3 

clinical_engagement 
diagnosis 
demography 
211 new agents 
14 
disease_progression 
H-positive risk:  863 884 134 928 408 132 875 407 127 59 117 66 
H-negative risk:  884 863 875 928 407 408 132 134 117 127 66 59 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 19 3 

clinical_engagement 
diagnosis 
demography 
57 new agents 
15 
disease_progression 
H-positive risk:  865 885 134 926 406 134 880 401 128 58 119 64 
H-negative risk:  885 865 880 926 401 406 134 134 119 128 64 58 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 21 3 

clinical_engagement 
diagnosis 
demography 
67 new agents 
16 
disease_progression 
H-positive risk:  872 889 134 934 401 134 878 388 127 59 121 63 
H-negative risk:  889 872 878 934 388 401 134 134 121 127 63 59 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 23 3 

clinical_engagement 
diagnosis 
demography 
47 new agents 
17 
disease_progression 
H-positive risk:  873 892 134 932 398 135 881 386 126 58 123 62 
H-negative risk:  892 873 881 932 386 398 135 134 123 126 62 58 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 26 3 

clinical_engagement 
diagnosis 
demography 
66 new agents 
18 
disease_progression 
H-positive risk:  883 898 134 929 396 134 881 375 128 59 120 63 
H-negative risk:  898 883 881 929 375 396 134 134 120 128 63 59 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 27 3 

clinical_engagement 
diagnosis 
demography 
64 new agents 
19 
disease_progression 
H-positive risk:  885 905 133 923 390 135 888 377 126 57 118 63 
H-negative risk:  905 885 888 923 377 390 135 133 118 126 63 57 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 31 3 

clinical_engagement 
diagnosis 
demography 
70 new agents 
20 
disease_progression 
H-positive risk:  887 909 133 920 391 137 888 370 126 56 120 63 
H-negative risk:  909 887 888 920 370 391 137 133 120 126 63 56 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 32 3 

clinical_engagement 
diagnosis 
demography 
65 new agents 
21 
disease_progression 
H-positive risk:  891 915 132 913 389 137 889 371 127 53 123 60 
H-negative risk:  915 891 889 913 371 389 137 132 123 127 60 53 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 32 5 

clinical_engagement 
diagnosis 
demography 
54 new agents 
22 
disease_progression 
H-positive risk:  898 918 132 915 381 137 881 377 126 53 121 61 
H-negative risk:  918 898 881 915 377 381 137 132 121 126 61 53 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 33 5 

clinical_engagement 
diagnosis 
demography 
51 new agents 
23 
disease_progression 
H-positive risk:  907 923 131 908 379 137 879 374 127 53 122 60 
H-negative risk:  923 907 879 908 374 379 137 131 122 127 60 53 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 35 6 

clinical_engagement 
diagnosis 
demography 
60 new agents 
24 
disease_progression 
H-positive risk:  905 923 130 904 377 139 889 371 125 51 126 60 
H-negative risk:  923 905 889 904 371 377 139 130 126 125 60 51 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 35 6 

clinical_engagement 
diagnosis 
demography 
62 new agents 
25 
disease_progression 
H-positive risk:  834 858 118 969 378 128 963 374 133 51 132 62 
H-negative risk:  858 834 963 969 374 378 128 118 132 133 62 51 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 36 7 

clinical_engagement 
diagnosis 
demography 
182 new agents 
26 
disease_progression 
H-positive risk:  869 872 126 919 398 133 905 400 120 58 135 65 
H-negative risk:  872 869 905 919 400 398 133 126 135 120 65 58 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 38 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
27 
disease_progression 
H-positive risk:  873 876 129 908 399 133 905 399 121 58 135 64 
H-negative risk:  876 873 905 908 399 399 133 129 135 121 64 58 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 40 6 

clinical_engagement 
diagnosis 
demography 
55 new agents 
28 
disease_progression 
H-positive risk:  876 880 131 909 392 136 897 395 122 61 138 63 
H-negative risk:  880 876 897 909 395 392 136 131 138 122 63 61 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 41 5 

clinical_engagement 
diagnosis 
demography 
63 new agents 
29 
disease_progression 
H-positive risk:  879 884 131 908 384 135 904 391 124 59 138 63 
H-negative risk:  884 879 904 908 391 384 135 131 138 124 63 59 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 41 5 

clinical_engagement 
diagnosis 
demography 
78 new agents 
30 
disease_progression 
H-positive risk:  879 892 134 910 380 136 897 387 126 58 138 63 
H-negative risk:  892 879 897 910 387 380 136 134 138 126 63 58 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 45 5 

clinical_engagement 
diagnosis 
demography 
56 new agents 
31 
disease_progression 
H-positive risk:  879 888 133 915 374 138 895 393 129 58 138 60 
H-negative risk:  888 879 895 915 393 374 138 133 138 129 60 58 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 49 5 

clinical_engagement 
diagnosis 
demography 
55 new agents 
32 
disease_progression 
H-positive risk:  881 891 133 918 366 138 890 400 128 58 137 60 
H-negative risk:  891 881 890 918 400 366 138 133 137 128 60 58 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 47 6 

clinical_engagement 
diagnosis 
demography 
66 new agents 
33 
disease_progression 
H-positive risk:  884 896 133 919 360 140 889 399 130 55 135 60 
H-negative risk:  896 884 889 919 399 360 140 133 135 130 60 55 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 51 6 

clinical_engagement 
diagnosis 
demography 
70 new agents 
34 
disease_progression 
H-positive risk:  884 900 138 920 354 135 896 389 129 57 135 63 
H-negative risk:  900 884 896 920 389 354 135 138 135 129 63 57 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 51 9 

clinical_engagement 
diagnosis 
demography 
55 new agents 
35 
disease_progression 
H-positive risk:  889 906 136 914 358 138 888 389 127 58 133 64 
H-negative risk:  906 889 888 914 389 358 138 136 133 127 64 58 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 51 9 

clinical_engagement 
diagnosis 
demography 
53 new agents 
36 
disease_progression 
H-positive risk:  891 902 138 913 359 139 893 381 127 61 133 63 
H-negative risk:  902 891 893 913 381 359 139 138 133 127 63 61 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 53 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
37 
disease_progression 
H-positive risk:  826 832 128 989 355 131 955 377 139 61 144 63 
H-negative risk:  832 826 955 989 377 355 131 128 144 139 63 61 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 54 8 

clinical_engagement 
diagnosis 
demography 
174 new agents 
38 
disease_progression 
H-positive risk:  842 855 129 952 371 138 902 408 136 65 144 58 
H-negative risk:  855 842 902 952 408 371 138 129 144 136 58 65 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 57 9 

clinical_engagement 
diagnosis 
demography 
77 new agents 
39 
disease_progression 
H-positive risk:  849 863 129 946 369 136 896 409 134 64 146 59 
H-negative risk:  863 849 896 946 409 369 136 129 146 134 59 64 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 58 9 

clinical_engagement 
diagnosis 
demography 
62 new agents 
40 
disease_progression 
H-positive risk:  852 864 130 946 363 141 891 412 132 65 141 63 
H-negative risk:  864 852 891 946 412 363 141 130 141 132 63 65 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 61 8 

clinical_engagement 
diagnosis 
demography 
70 new agents 
41 
disease_progression 
H-positive risk:  855 863 132 942 362 142 891 410 132 66 141 64 
H-negative risk:  863 855 891 942 410 362 142 132 141 132 64 66 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 63 7 

clinical_engagement 
diagnosis 
demography 
61 new agents 
42 
disease_progression 
H-positive risk:  857 865 133 952 368 140 883 403 131 64 141 63 
H-negative risk:  865 857 883 952 403 368 140 133 141 131 63 64 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 63 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
43 
disease_progression 
H-positive risk:  856 868 132 951 366 140 889 401 135 61 141 60 
H-negative risk:  868 856 889 951 401 366 140 132 141 135 60 61 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 62 9 

clinical_engagement 
diagnosis 
demography 
72 new agents 
44 
disease_progression 
H-positive risk:  855 871 135 945 364 143 891 406 132 60 141 57 
H-negative risk:  871 855 891 945 406 364 143 135 141 132 57 60 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 62 9 

clinical_engagement 
diagnosis 
demography 
71 new agents 
45 
disease_progression 
H-positive risk:  861 873 133 946 364 144 896 395 133 59 141 55 
H-negative risk:  873 861 896 946 395 364 144 133 141 133 55 59 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 60 11 

clinical_engagement 
diagnosis 
demography 
71 new agents 
46 
disease_progression 
H-positive risk:  861 874 133 938 356 144 899 399 135 58 148 55 
H-negative risk:  874 861 899 938 399 356 144 133 148 135 55 58 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 60 11 

clinical_engagement 
diagnosis 
demography 
66 new agents 
47 
disease_progression 
H-positive risk:  870 876 133 945 352 143 896 391 135 58 148 53 
H-negative risk:  876 870 896 945 391 352 143 133 148 135 53 58 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 59 12 

clinical_engagement 
diagnosis 
demography 
57 new agents 
48 
disease_progression 
H-positive risk:  878 879 135 940 351 146 900 386 132 53 148 52 
H-negative risk:  879 878 900 940 386 351 146 135 148 132 52 53 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 61 13 

clinical_engagement 
diagnosis 
demography 
55 new agents 
49 
disease_progression 
H-positive risk:  835 827 132 997 348 135 944 384 139 54 152 53 
H-negative risk:  827 835 944 997 384 348 135 132 152 139 53 54 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 67 15 

clinical_engagement 
diagnosis 
demography 
150 new agents 
50 
disease_progression 
H-positive risk:  855 827 132 976 362 133 942 389 135 50 150 49 
H-negative risk:  827 855 942 976 389 362 133 132 150 135 49 50 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
51 
disease_progression 
H-positive risk:  855 835 129 969 361 134 946 388 137 50 148 48 
H-negative risk:  835 855 946 969 388 361 134 129 148 137 48 50 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 65 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
52 
disease_progression 
H-positive risk:  852 839 130 972 355 133 942 391 139 51 147 49 
H-negative risk:  839 852 942 972 391 355 133 130 147 139 49 51 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
53 
disease_progression 
H-positive risk:  856 841 129 972 362 130 940 386 140 50 148 46 
H-negative risk:  841 856 940 972 386 362 130 129 148 140 46 50 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
54 
disease_progression 
H-positive risk:  859 850 127 973 360 127 935 383 139 51 151 45 
H-negative risk:  850 859 935 973 383 360 127 127 151 139 45 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
55 
disease_progression 
H-positive risk:  857 853 130 975 358 126 938 373 141 53 152 44 
H-negative risk:  853 857 938 975 373 358 126 130 152 141 44 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
56 
disease_progression 
H-positive risk:  861 859 130 968 356 128 940 370 141 52 151 44 
H-negative risk:  859 861 940 968 370 356 128 130 151 141 44 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
53 new agents 
57 
disease_progression 
H-positive risk:  860 860 130 970 356 127 938 371 142 54 148 44 
H-negative risk:  860 860 938 970 371 356 127 130 148 142 44 54 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
54 new agents 
58 
disease_progression 
H-positive risk:  855 862 130 975 355 129 933 377 140 54 148 42 
H-negative risk:  862 855 933 975 377 355 129 130 148 140 42 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
51 new agents 
59 
disease_progression 
H-positive risk:  854 870 131 977 359 127 928 373 138 54 146 43 
H-negative risk:  870 854 928 977 373 359 127 131 146 138 43 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
60 
disease_progression 
H-positive risk:  858 874 132 978 355 127 928 371 137 52 147 41 
H-negative risk:  874 858 928 978 371 355 127 132 147 137 41 52 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
61 
disease_progression 
H-positive risk:  808 837 123 1011 356 121 978 370 146 52 157 41 
H-negative risk:  837 808 978 1011 370 356 121 123 157 146 41 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
122 new agents 
62 
disease_progression 
H-positive risk:  810 846 125 982 370 120 970 383 142 56 155 41 
H-negative risk:  846 810 970 982 383 370 120 125 155 142 41 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
63 
disease_progression 
H-positive risk:  816 841 127 982 367 118 973 384 142 56 153 41 
H-negative risk:  841 816 973 982 384 367 118 127 153 142 41 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
64 
disease_progression 
H-positive risk:  823 843 125 981 360 118 968 384 144 55 156 43 
H-negative risk:  843 823 968 981 384 360 118 125 156 144 43 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
65 
disease_progression 
H-positive risk:  819 847 127 984 360 119 967 383 143 55 156 40 
H-negative risk:  847 819 967 984 383 360 119 127 156 143 40 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
66 
disease_progression 
H-positive risk:  824 844 128 978 365 120 960 381 145 58 155 42 
H-negative risk:  844 824 960 978 381 365 120 128 155 145 42 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
67 
disease_progression 
H-positive risk:  825 849 129 970 366 122 967 374 145 57 153 43 
H-negative risk:  849 825 967 970 374 366 122 129 153 145 43 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
68 
disease_progression 
H-positive risk:  822 844 128 966 368 121 977 371 145 59 155 44 
H-negative risk:  844 822 977 966 371 368 121 128 155 145 44 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
69 
disease_progression 
H-positive risk:  824 848 130 959 377 122 966 372 147 58 153 44 
H-negative risk:  848 824 966 959 372 377 122 130 153 147 44 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
70 
disease_progression 
H-positive risk:  828 851 130 955 374 121 968 373 149 57 150 44 
H-negative risk:  851 828 968 955 373 374 121 130 150 149 44 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
71 
disease_progression 
H-positive risk:  826 855 135 953 372 121 969 372 150 54 151 42 
H-negative risk:  855 826 969 953 372 372 121 135 151 150 42 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
72 
disease_progression 
H-positive risk:  824 853 134 953 375 123 975 361 151 54 153 44 
H-negative risk:  853 824 975 953 361 375 123 134 153 151 44 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
73 
disease_progression 
H-positive risk:  782 816 124 991 376 114 1019 358 158 54 164 44 
H-negative risk:  816 782 1019 991 358 376 114 124 164 158 44 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
113 new agents 
74 
disease_progression 
H-positive risk:  779 816 124 977 391 115 1007 372 159 55 157 48 
H-negative risk:  816 779 1007 977 372 391 115 124 157 159 48 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
75 
disease_progression 
H-positive risk:  780 809 125 974 407 116 999 370 158 57 154 51 
H-negative risk:  809 780 999 974 370 407 116 125 154 158 51 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
58 new agents 
76 
disease_progression 
H-positive risk:  777 808 125 978 408 115 998 366 159 60 154 52 
H-negative risk:  808 777 998 978 366 408 115 125 154 159 52 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
77 
disease_progression 
H-positive risk:  773 814 122 982 409 114 1003 362 159 61 152 49 
H-negative risk:  814 773 1003 982 362 409 114 122 152 159 49 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
78 
disease_progression 
H-positive risk:  772 808 122 984 408 113 1010 367 158 61 149 48 
H-negative risk:  808 772 1010 984 367 408 113 122 149 158 48 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  769 806 121 987 406 115 1013 362 161 60 153 47 
H-negative risk:  806 769 1013 987 362 406 115 121 153 161 47 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
80 
disease_progression 
H-positive risk:  776 803 122 981 412 115 1014 354 162 59 156 46 
H-negative risk:  803 776 1014 981 354 412 115 122 156 162 46 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
81 
disease_progression 
H-positive risk:  771 808 122 994 402 115 1018 351 160 63 152 44 
H-negative risk:  808 771 1018 994 351 402 115 122 152 160 44 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
82 
disease_progression 
H-positive risk:  777 808 121 999 403 113 1015 350 162 61 149 42 
H-negative risk:  808 777 1015 999 350 403 113 121 149 162 42 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
83 
disease_progression 
H-positive risk:  785 803 120 1002 404 115 1016 348 161 57 149 40 
H-negative risk:  803 785 1016 1002 348 404 115 120 149 161 40 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
84 
disease_progression 
H-positive risk:  790 796 121 992 405 113 1024 347 160 61 149 42 
H-negative risk:  796 790 1024 992 347 405 113 121 149 160 42 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
85 
disease_progression 
H-positive risk:  739 734 112 1051 407 107 1072 349 165 63 162 39 
H-negative risk:  734 739 1072 1051 349 407 107 112 162 165 39 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
110 new agents 
86 
disease_progression 
H-positive risk:  743 740 109 1052 404 104 1061 359 162 64 159 43 
H-negative risk:  740 743 1061 1052 359 404 104 109 159 162 43 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
87 
disease_progression 
H-positive risk:  760 734 113 1047 400 102 1049 365 164 65 157 44 
H-negative risk:  734 760 1049 1047 365 400 102 113 157 164 44 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
53 new agents 
88 
disease_progression 
H-positive risk:  762 738 113 1042 398 102 1046 367 166 64 159 43 
H-negative risk:  738 762 1046 1042 367 398 102 113 159 166 43 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
89 
disease_progression 
H-positive risk:  763 740 114 1045 395 101 1055 356 164 66 158 43 
H-negative risk:  740 763 1055 1045 356 395 101 114 158 164 43 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
90 
disease_progression 
H-positive risk:  771 739 113 1044 392 100 1051 358 163 66 158 45 
H-negative risk:  739 771 1051 1044 358 392 100 113 158 163 45 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
91 
disease_progression 
H-positive risk:  772 739 116 1046 393 100 1046 363 159 64 155 47 
H-negative risk:  739 772 1046 1046 363 393 100 116 155 159 47 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
52 new agents 
92 
disease_progression 
H-positive risk:  769 735 116 1047 395 100 1050 359 161 63 157 48 
H-negative risk:  735 769 1050 1047 359 395 100 116 157 161 48 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
93 
disease_progression 
H-positive risk:  778 740 116 1044 399 99 1038 360 157 63 159 47 
H-negative risk:  740 778 1038 1044 360 399 99 116 159 157 47 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
94 
disease_progression 
H-positive risk:  775 746 115 1041 394 100 1040 361 158 60 159 51 
H-negative risk:  746 775 1040 1041 361 394 100 115 159 158 51 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
95 
disease_progression 
H-positive risk:  773 749 115 1040 402 101 1035 359 155 62 158 51 
H-negative risk:  749 773 1035 1040 359 402 101 115 158 155 51 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
96 
disease_progression 
H-positive risk:  770 747 114 1045 399 98 1039 360 160 58 160 50 
H-negative risk:  747 770 1039 1045 360 399 98 114 160 160 50 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
97 
disease_progression 
H-positive risk:  726 703 111 1102 391 90 1075 364 166 59 162 51 
H-negative risk:  703 726 1075 1102 364 391 90 111 162 166 51 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
98 
disease_progression 
H-positive risk:  708 696 112 1090 414 89 1073 379 164 60 158 57 
H-negative risk:  696 708 1073 1090 379 414 89 112 158 164 57 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
97 new agents 
99 
disease_progression 
H-positive risk:  713 702 111 1092 410 88 1070 378 163 59 159 55 
H-negative risk:  702 713 1070 1092 378 410 88 111 159 163 55 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
100 
disease_progression 
H-positive risk:  711 706 112 1086 405 87 1079 378 165 55 161 55 
H-negative risk:  706 711 1079 1086 378 405 87 112 161 165 55 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
101 
disease_progression 
H-positive risk:  711 707 112 1088 404 88 1069 381 165 56 164 55 
H-negative risk:  707 711 1069 1088 381 404 88 112 164 165 55 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  705 713 114 1086 401 89 1070 383 163 54 167 55 
H-negative risk:  713 705 1070 1086 383 401 89 114 167 163 55 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
103 
disease_progression 
H-positive risk:  706 719 115 1081 394 89 1071 385 162 54 164 60 
H-negative risk:  719 706 1071 1081 385 394 89 115 164 162 60 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
104 
disease_progression 
H-positive risk:  710 717 116 1079 400 88 1066 387 161 56 163 57 
H-negative risk:  717 710 1066 1079 387 400 88 116 163 161 57 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
105 
disease_progression 
H-positive risk:  713 714 115 1089 400 90 1053 393 158 56 162 57 
H-negative risk:  714 713 1053 1089 393 400 90 115 162 158 57 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
106 
disease_progression 
H-positive risk:  713 720 116 1091 402 92 1058 387 158 52 157 54 
H-negative risk:  720 713 1058 1091 387 402 92 116 157 158 54 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
107 
disease_progression 
H-positive risk:  709 725 115 1095 398 92 1064 381 159 49 158 55 
H-negative risk:  725 709 1064 1095 381 398 92 115 158 159 55 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
108 
disease_progression 
H-positive risk:  705 729 118 1098 403 94 1065 372 157 45 159 55 
H-negative risk:  729 705 1065 1098 372 403 94 118 159 157 55 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
109 
disease_progression 
H-positive risk:  661 676 110 1148 405 86 1113 368 165 46 166 56 
H-negative risk:  676 661 1113 1148 368 405 86 110 166 165 56 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
110 
disease_progression 
H-positive risk:  652 665 107 1147 413 87 1110 387 162 47 159 64 
H-negative risk:  665 652 1110 1147 387 413 87 107 159 162 64 47 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
111 
disease_progression 
H-positive risk:  657 663 105 1141 412 88 1107 391 163 47 162 64 
H-negative risk:  663 657 1107 1141 391 412 88 105 162 163 64 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
100 new agents 
112 
disease_progression 
H-positive risk:  657 662 103 1147 403 92 1118 388 162 46 160 62 
H-negative risk:  662 657 1118 1147 388 403 92 103 160 162 62 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  667 661 104 1145 404 92 1110 387 161 46 164 59 
H-negative risk:  661 667 1110 1145 387 404 92 104 164 161 59 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
114 
disease_progression 
H-positive risk:  675 661 108 1136 402 92 1109 388 161 44 165 59 
H-negative risk:  661 675 1109 1136 388 402 92 108 165 161 59 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
115 
disease_progression 
H-positive risk:  685 662 110 1134 398 92 1103 386 161 43 167 59 
H-negative risk:  662 685 1103 1134 386 398 92 110 167 161 59 43 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
116 
disease_progression 
H-positive risk:  686 663 110 1131 397 92 1107 388 159 42 166 59 
H-negative risk:  663 686 1107 1131 388 397 92 110 166 159 59 42 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
117 
disease_progression 
H-positive risk:  690 657 110 1138 392 92 1119 380 155 40 168 59 
H-negative risk:  657 690 1119 1138 380 392 92 110 168 155 59 40 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
118 
disease_progression 
H-positive risk:  692 649 110 1151 387 92 1115 385 157 40 165 57 
H-negative risk:  649 692 1115 1151 385 387 92 110 165 157 57 40 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
119 
disease_progression 
H-positive risk:  693 644 112 1149 386 93 1124 383 156 40 162 58 
H-negative risk:  644 693 1124 1149 383 386 93 112 162 156 58 40 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
120 
disease_progression 
H-positive risk:  688 648 110 1144 389 93 1128 385 153 39 168 55 
H-negative risk:  648 688 1128 1144 385 389 93 110 168 153 55 39 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
121 
disease_progression 
H-positive risk:  636 602 104 1198 388 86 1179 388 157 39 171 52 
H-negative risk:  602 636 1179 1198 388 388 86 104 171 157 52 39 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
115 new agents 
122 
disease_progression 
H-positive risk:  637 607 102 1194 389 90 1178 390 150 39 169 55 
H-negative risk:  607 637 1178 1194 390 389 90 102 169 150 55 39 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
123 
disease_progression 
H-positive risk:  640 609 100 1190 384 89 1177 392 151 41 169 58 
H-negative risk:  609 640 1177 1190 392 384 89 100 169 151 58 41 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
124 
disease_progression 
H-positive risk:  640 620 102 1185 380 88 1166 391 154 42 170 62 
H-negative risk:  620 640 1166 1185 391 380 88 102 170 154 62 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
125 
disease_progression 
H-positive risk:  644 622 103 1187 378 86 1148 401 154 42 173 62 
H-negative risk:  622 644 1148 1187 401 378 86 103 173 154 62 42 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
126 
disease_progression 
H-positive risk:  647 623 108 1178 377 87 1142 406 153 42 175 62 
H-negative risk:  623 647 1142 1178 406 377 87 108 175 153 62 42 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
127 
disease_progression 
H-positive risk:  654 617 105 1183 378 86 1142 404 155 42 175 59 
H-negative risk:  617 654 1142 1183 404 378 86 105 175 155 59 42 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
128 
disease_progression 
H-positive risk:  656 632 104 1171 379 85 1138 403 156 44 173 59 
H-negative risk:  632 656 1138 1171 403 379 85 104 173 156 59 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
129 
disease_progression 
H-positive risk:  658 632 99 1178 369 85 1143 399 155 45 176 61 
H-negative risk:  632 658 1143 1178 399 369 85 99 176 155 61 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
130 
disease_progression 
H-positive risk:  656 632 97 1182 370 85 1139 402 157 47 172 61 
H-negative risk:  632 656 1139 1182 402 370 85 97 172 157 61 47 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
131 
disease_progression 
H-positive risk:  658 631 97 1173 373 85 1142 399 158 50 173 61 
H-negative risk:  631 658 1142 1173 399 373 85 97 173 158 61 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
132 
disease_progression 
H-positive risk:  659 635 98 1168 372 88 1137 393 161 50 177 62 
H-negative risk:  635 659 1137 1168 393 372 88 98 177 161 62 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
133 
disease_progression 
H-positive risk:  656 642 98 1159 380 87 1138 390 162 52 174 62 
H-negative risk:  642 656 1138 1159 390 380 87 98 174 162 62 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
134 
disease_progression 
H-positive risk:  644 642 95 1155 389 85 1137 397 162 52 180 62 
H-negative risk:  642 644 1137 1155 397 389 85 95 180 162 62 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
135 
disease_progression 
H-positive risk:  637 638 94 1152 399 86 1141 397 162 52 179 63 
H-negative risk:  638 637 1141 1152 397 399 86 94 179 162 63 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
136 
disease_progression 
H-positive risk:  639 643 94 1156 398 86 1145 390 160 51 177 61 
H-negative risk:  643 639 1145 1156 390 398 86 94 177 160 61 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
137 
disease_progression 
H-positive risk:  639 638 92 1159 391 87 1158 389 158 51 180 58 
H-negative risk:  638 639 1158 1159 389 391 87 92 180 158 58 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
138 
disease_progression 
H-positive risk:  638 637 86 1169 383 88 1153 396 159 49 183 59 
H-negative risk:  637 638 1153 1169 396 383 88 86 183 159 59 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
139 
disease_progression 
H-positive risk:  642 632 84 1182 374 90 1161 386 156 50 180 63 
H-negative risk:  632 642 1161 1182 386 374 90 84 180 156 63 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
140 
disease_progression 
H-positive risk:  640 637 86 1170 379 90 1167 381 156 53 179 62 
H-negative risk:  637 640 1167 1170 381 379 90 86 179 156 62 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
141 
disease_progression 
H-positive risk:  642 643 86 1163 380 90 1173 374 158 51 177 63 
H-negative risk:  643 642 1173 1163 374 380 90 86 177 158 63 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
142 
disease_progression 
H-positive risk:  642 653 89 1163 383 89 1169 365 158 49 177 63 
H-negative risk:  653 642 1169 1163 365 383 89 89 177 158 63 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
143 
disease_progression 
H-positive risk:  653 653 89 1156 378 89 1160 376 159 48 173 66 
H-negative risk:  653 653 1160 1156 376 378 89 89 173 159 66 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
144 
disease_progression 
H-positive risk:  654 652 90 1162 381 88 1154 374 158 47 175 65 
H-negative risk:  652 654 1154 1162 374 381 88 90 175 158 65 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
145 
disease_progression 
H-positive risk:  657 653 92 1154 385 89 1143 384 157 45 175 66 
H-negative risk:  653 657 1143 1154 384 385 89 92 175 157 66 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
146 
disease_progression 
H-positive risk:  656 649 91 1160 383 86 1128 400 158 46 175 68 
H-negative risk:  649 656 1128 1160 400 383 86 91 175 158 68 46 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
147 
disease_progression 
H-positive risk:  657 644 91 1163 386 86 1136 395 156 47 171 68 
H-negative risk:  644 657 1136 1163 395 386 86 91 171 156 68 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
148 
disease_progression 
H-positive risk:  660 650 91 1164 381 85 1127 400 157 48 171 66 
H-negative risk:  650 660 1127 1164 400 381 85 91 171 157 66 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
149 
disease_progression 
H-positive risk:  655 650 88 1155 391 87 1133 401 157 49 169 65 
H-negative risk:  650 655 1133 1155 401 391 87 88 169 157 65 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
150 
disease_progression 
H-positive risk:  650 645 87 1164 393 85 1128 404 160 48 171 65 
H-negative risk:  645 650 1128 1164 404 393 85 87 171 160 65 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
151 
disease_progression 
H-positive risk:  641 653 88 1161 388 84 1129 407 165 47 173 64 
H-negative risk:  653 641 1129 1161 407 388 84 88 173 165 64 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
56 new agents 
152 
disease_progression 
H-positive risk:  636 655 87 1158 390 83 1128 409 167 49 174 64 
H-negative risk:  655 636 1128 1158 409 390 83 87 174 167 64 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
153 
disease_progression 
H-positive risk:  641 655 84 1144 387 86 1132 412 172 46 179 62 
H-negative risk:  655 641 1132 1144 412 387 86 84 179 172 62 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
154 
disease_progression 
H-positive risk:  642 656 83 1148 395 89 1130 406 166 44 177 64 
H-negative risk:  656 642 1130 1148 406 395 89 83 177 166 64 44 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
155 
disease_progression 
H-positive risk:  649 650 85 1161 398 86 1126 402 166 42 177 58 
H-negative risk:  650 649 1126 1161 402 398 86 85 177 166 58 42 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
156 
disease_progression 
H-positive risk:  650 647 85 1162 401 88 1130 394 167 41 178 57 
H-negative risk:  647 650 1130 1162 394 401 88 85 178 167 57 41 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
157 
disease_progression 
H-positive risk:  648 655 83 1164 398 87 1132 393 165 42 174 59 
H-negative risk:  655 648 1132 1164 393 398 87 83 174 165 59 42 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
100 new agents 
158 
disease_progression 
H-positive risk:  658 666 85 1150 402 88 1115 398 166 46 167 59 
H-negative risk:  666 658 1115 1150 398 402 88 85 167 166 59 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
159 
disease_progression 
H-positive risk:  655 675 87 1151 403 87 1107 399 166 45 164 61 
H-negative risk:  675 655 1107 1151 399 403 87 87 164 166 61 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
160 
disease_progression 
H-positive risk:  650 674 88 1154 404 86 1106 400 166 45 166 61 
H-negative risk:  674 650 1106 1154 400 404 86 88 166 166 61 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
90 new agents 
161 
disease_progression 
H-positive risk:  652 678 90 1147 410 86 1097 401 164 50 163 62 
H-negative risk:  678 652 1097 1147 401 410 86 90 163 164 62 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
162 
disease_progression 
H-positive risk:  657 677 90 1152 409 84 1090 398 169 49 164 61 
H-negative risk:  677 657 1090 1152 398 409 84 90 164 169 61 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
163 
disease_progression 
H-positive risk:  656 666 88 1156 406 85 1093 404 170 48 167 61 
H-negative risk:  666 656 1093 1156 404 406 85 88 167 170 61 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
164 
disease_progression 
H-positive risk:  661 673 86 1148 409 85 1089 407 167 49 166 60 
H-negative risk:  673 661 1089 1148 407 409 85 86 166 167 60 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
165 
disease_progression 
H-positive risk:  665 673 84 1154 411 85 1088 405 166 47 165 57 
H-negative risk:  673 665 1088 1154 405 411 85 84 165 166 57 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
166 
disease_progression 
H-positive risk:  670 678 81 1149 405 86 1087 402 164 48 169 61 
H-negative risk:  678 670 1087 1149 402 405 86 81 169 164 61 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  673 676 81 1151 402 85 1090 401 164 47 168 62 
H-negative risk:  676 673 1090 1151 401 402 85 81 168 164 62 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
168 
disease_progression 
H-positive risk:  684 680 83 1147 401 84 1084 392 161 52 171 61 
H-negative risk:  680 684 1084 1147 392 401 84 83 171 161 61 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
169 
disease_progression 
H-positive risk:  682 672 82 1157 398 86 1087 391 159 55 169 62 
H-negative risk:  672 682 1087 1157 391 398 86 82 169 159 62 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
170 
disease_progression 
H-positive risk:  686 682 83 1146 406 84 1077 394 162 53 166 61 
H-negative risk:  682 686 1077 1146 394 406 84 83 166 162 61 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
171 
disease_progression 
H-positive risk:  679 683 83 1148 405 86 1077 397 159 57 163 63 
H-negative risk:  683 679 1077 1148 397 405 86 83 163 159 63 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
172 
disease_progression 
H-positive risk:  680 691 82 1141 405 84 1078 396 162 54 163 64 
H-negative risk:  691 680 1078 1141 396 405 84 82 163 162 64 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
173 
disease_progression 
H-positive risk:  678 695 83 1140 398 85 1086 395 165 53 159 63 
H-negative risk:  695 678 1086 1140 395 398 85 83 159 165 63 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
174 
disease_progression 
H-positive risk:  684 690 86 1140 398 86 1086 391 159 53 162 65 
H-negative risk:  690 684 1086 1140 391 398 86 86 162 159 65 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
175 
disease_progression 
H-positive risk:  678 689 86 1143 395 86 1085 394 159 53 164 68 
H-negative risk:  689 678 1085 1143 394 395 86 86 164 159 68 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
176 
disease_progression 
H-positive risk:  681 690 87 1133 390 88 1093 397 159 55 162 65 
H-negative risk:  690 681 1093 1133 397 390 88 87 162 159 65 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
177 
disease_progression 
H-positive risk:  673 693 87 1130 388 88 1101 399 157 54 163 67 
H-negative risk:  693 673 1101 1130 399 388 88 87 163 157 67 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
178 
disease_progression 
H-positive risk:  683 689 91 1135 387 88 1084 397 157 58 163 68 
H-negative risk:  689 683 1084 1135 397 387 88 91 163 157 68 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
179 
disease_progression 
H-positive risk:  685 699 90 1123 396 88 1080 393 155 59 164 68 
H-negative risk:  699 685 1080 1123 393 396 88 90 164 155 68 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
180 
disease_progression 
H-positive risk:  683 696 91 1119 402 87 1082 397 153 60 163 67 
H-negative risk:  696 683 1082 1119 397 402 87 91 163 153 67 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
181 
disease_progression 
H-positive risk:  684 694 93 1115 398 87 1082 398 155 61 162 71 
H-negative risk:  694 684 1082 1115 398 398 87 93 162 155 71 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
182 
disease_progression 
H-positive risk:  683 695 94 1117 402 87 1058 416 156 60 162 70 
H-negative risk:  695 683 1058 1117 416 402 87 94 162 156 70 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
183 
disease_progression 
H-positive risk:  682 689 93 1124 394 88 1061 419 157 59 163 71 
H-negative risk:  689 682 1061 1124 419 394 88 93 163 157 71 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
93 new agents 
184 
disease_progression 
H-positive risk:  690 692 94 1126 399 89 1055 410 157 58 162 68 
H-negative risk:  692 690 1055 1126 410 399 89 94 162 157 68 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
185 
disease_progression 
H-positive risk:  689 696 95 1127 396 89 1059 406 157 60 161 65 
H-negative risk:  696 689 1059 1127 406 396 89 95 161 157 65 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
186 
disease_progression 
H-positive risk:  689 690 95 1122 396 86 1077 403 161 57 160 64 
H-negative risk:  690 689 1077 1122 403 396 86 95 160 161 64 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
187 
disease_progression 
H-positive risk:  693 694 96 1123 398 85 1076 398 161 54 155 67 
H-negative risk:  694 693 1076 1123 398 398 85 96 155 161 67 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
188 
disease_progression 
H-positive risk:  688 693 97 1131 401 86 1074 396 161 53 154 66 
H-negative risk:  693 688 1074 1131 396 401 86 97 154 161 66 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
189 
disease_progression 
H-positive risk:  692 688 100 1142 394 87 1068 394 164 53 149 69 
H-negative risk:  688 692 1068 1142 394 394 87 100 149 164 69 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
190 
disease_progression 
H-positive risk:  688 692 98 1132 395 86 1078 392 164 56 150 69 
H-negative risk:  692 688 1078 1132 392 395 86 98 150 164 69 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
191 
disease_progression 
H-positive risk:  686 693 100 1123 396 88 1084 388 164 58 151 69 
H-negative risk:  693 686 1084 1123 388 396 88 100 151 164 69 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
192 
disease_progression 
H-positive risk:  684 693 98 1129 398 86 1084 389 166 56 150 67 
H-negative risk:  693 684 1084 1129 389 398 86 98 150 166 67 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
193 
disease_progression 
H-positive risk:  691 693 102 1131 393 88 1076 390 165 55 149 67 
H-negative risk:  693 691 1076 1131 390 393 88 102 149 165 67 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
194 
disease_progression 
H-positive risk:  687 695 100 1121 404 89 1064 403 163 55 148 71 
H-negative risk:  695 687 1064 1121 403 404 89 100 148 163 71 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
195 
disease_progression 
H-positive risk:  685 700 102 1112 402 92 1049 417 162 58 150 71 
H-negative risk:  700 685 1049 1112 417 402 92 102 150 162 71 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
196 
disease_progression 
H-positive risk:  680 701 102 1104 411 92 1049 420 163 57 150 71 
H-negative risk:  701 680 1049 1104 420 411 92 102 150 163 71 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
197 
disease_progression 
H-positive risk:  682 704 103 1096 411 96 1045 429 162 54 147 71 
H-negative risk:  704 682 1045 1096 429 411 96 103 147 162 71 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
198 
disease_progression 
H-positive risk:  683 696 105 1095 405 98 1058 426 161 56 149 68 
H-negative risk:  696 683 1058 1095 426 405 98 105 149 161 68 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
199 
disease_progression 
H-positive risk:  684 700 108 1091 401 98 1064 421 160 56 149 68 
H-negative risk:  700 684 1064 1091 421 401 98 108 149 160 68 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
200 
disease_progression 
H-positive risk:  674 696 108 1097 397 99 1076 426 155 59 147 66 
H-negative risk:  696 674 1076 1097 426 397 99 108 147 155 66 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
201 
disease_progression 
H-positive risk:  680 694 107 1095 391 99 1079 428 159 57 146 65 
H-negative risk:  694 680 1079 1095 428 391 99 107 146 159 65 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
202 
disease_progression 
H-positive risk:  680 691 110 1107 390 96 1078 424 156 59 143 66 
H-negative risk:  691 680 1078 1107 424 390 96 110 143 156 66 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
203 
disease_progression 
H-positive risk:  682 696 110 1097 401 99 1081 410 158 57 144 65 
H-negative risk:  696 682 1081 1097 410 401 99 110 144 158 65 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
204 
disease_progression 
H-positive risk:  683 703 111 1092 396 101 1082 409 157 55 146 65 
H-negative risk:  703 683 1082 1092 409 396 101 111 146 157 65 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
205 
disease_progression 
H-positive risk:  686 710 111 1084 398 99 1080 407 158 56 147 64 
H-negative risk:  710 686 1080 1084 407 398 99 111 147 158 64 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
85 new agents 
206 
disease_progression 
H-positive risk:  682 707 109 1070 421 102 1081 409 151 57 146 65 
H-negative risk:  707 682 1081 1070 409 421 102 109 146 151 65 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
207 
disease_progression 
H-positive risk:  670 700 109 1075 420 103 1097 405 152 60 145 64 
H-negative risk:  700 670 1097 1075 405 420 103 109 145 152 64 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
208 
disease_progression 
H-positive risk:  671 699 109 1070 423 102 1100 408 152 55 146 65 
H-negative risk:  699 671 1100 1070 408 423 102 109 146 152 65 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
209 
disease_progression 
H-positive risk:  668 702 108 1066 421 101 1103 406 154 54 149 68 
H-negative risk:  702 668 1103 1066 406 421 101 108 149 154 68 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
210 
disease_progression 
H-positive risk:  672 699 110 1063 427 100 1113 396 151 55 146 68 
H-negative risk:  699 672 1113 1063 396 427 100 110 146 151 68 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
211 
disease_progression 
H-positive risk:  676 698 108 1064 426 99 1110 393 153 55 147 71 
H-negative risk:  698 676 1110 1064 393 426 99 108 147 153 71 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
87 new agents 
212 
disease_progression 
H-positive risk:  682 701 105 1066 421 101 1103 392 153 58 150 68 
H-negative risk:  701 682 1103 1066 392 421 101 105 150 153 68 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
213 
disease_progression 
H-positive risk:  683 702 108 1061 421 105 1094 392 152 59 155 68 
H-negative risk:  702 683 1094 1061 392 421 105 108 155 152 68 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  686 694 105 1072 427 105 1090 392 150 59 155 65 
H-negative risk:  694 686 1090 1072 392 427 105 105 155 150 65 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
215 
disease_progression 
H-positive risk:  692 690 106 1081 427 103 1075 399 152 59 154 62 
H-negative risk:  690 692 1075 1081 399 427 103 106 154 152 62 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
216 
disease_progression 
H-positive risk:  686 692 107 1090 423 103 1081 399 149 61 152 57 
H-negative risk:  692 686 1081 1090 399 423 103 107 152 149 57 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
217 
disease_progression 
H-positive risk:  691 683 106 1084 429 103 1074 412 145 63 150 60 
H-negative risk:  683 691 1074 1084 412 429 103 106 150 145 60 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 76 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
218 
disease_progression 
H-positive risk:  690 693 104 1087 427 102 1077 401 146 58 154 61 
H-negative risk:  693 690 1077 1087 401 427 102 104 154 146 61 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
219 
disease_progression 
H-positive risk:  679 699 105 1086 430 103 1078 401 146 59 151 63 
H-negative risk:  699 679 1078 1086 401 430 103 105 151 146 63 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
91 new agents 
220 
disease_progression 
H-positive risk:  686 697 105 1095 436 106 1067 396 145 56 149 62 
H-negative risk:  697 686 1067 1095 396 436 106 105 149 145 62 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
221 
disease_progression 
H-positive risk:  689 695 107 1098 431 103 1075 389 147 57 150 59 
H-negative risk:  695 689 1075 1098 389 431 103 107 150 147 59 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
222 
disease_progression 
H-positive risk:  682 709 108 1097 438 104 1067 387 146 58 146 58 
H-negative risk:  709 682 1067 1097 387 438 104 108 146 146 58 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 69 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
223 
disease_progression 
H-positive risk:  684 703 109 1102 434 104 1068 387 146 59 146 58 
H-negative risk:  703 684 1068 1102 387 434 104 109 146 146 58 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
224 
disease_progression 
H-positive risk:  681 701 113 1103 426 101 1069 393 150 59 147 57 
H-negative risk:  701 681 1069 1103 393 426 101 113 147 150 57 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
225 
disease_progression 
H-positive risk:  682 702 113 1091 433 101 1071 392 152 61 148 54 
H-negative risk:  702 682 1071 1091 392 433 101 113 148 152 54 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
65 new agents 
226 
disease_progression 
H-positive risk:  679 703 113 1098 426 101 1072 393 153 60 149 53 
H-negative risk:  703 679 1072 1098 393 426 101 113 149 153 53 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
227 
disease_progression 
H-positive risk:  679 702 110 1097 419 103 1075 394 155 60 153 53 
H-negative risk:  702 679 1075 1097 394 419 103 110 153 155 53 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
228 
disease_progression 
H-positive risk:  682 705 106 1095 417 102 1079 392 156 58 154 54 
H-negative risk:  705 682 1079 1095 392 417 102 106 154 156 54 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
229 
disease_progression 
H-positive risk:  694 706 108 1090 424 102 1061 393 153 60 154 55 
H-negative risk:  706 694 1061 1090 393 424 102 108 154 153 55 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
230 
disease_progression 
H-positive risk:  696 705 108 1085 426 101 1068 388 153 63 151 56 
H-negative risk:  705 696 1068 1085 388 426 101 108 151 153 56 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
231 
disease_progression 
H-positive risk:  706 712 108 1074 430 99 1068 386 153 62 148 54 
H-negative risk:  712 706 1068 1074 386 430 99 108 148 153 54 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
232 
disease_progression 
H-positive risk:  703 702 108 1066 435 98 1075 389 151 67 150 56 
H-negative risk:  702 703 1075 1066 389 435 98 108 150 151 56 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
233 
disease_progression 
H-positive risk:  698 702 107 1077 428 98 1080 385 150 67 153 55 
H-negative risk:  702 698 1080 1077 385 428 98 107 153 150 55 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
234 
disease_progression 
H-positive risk:  693 712 111 1079 427 95 1082 374 150 67 154 56 
H-negative risk:  712 693 1082 1079 374 427 95 111 154 150 56 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
55 new agents 
235 
disease_progression 
H-positive risk:  679 710 109 1080 424 97 1089 382 150 70 152 58 
H-negative risk:  710 679 1089 1080 382 424 97 109 152 150 58 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
236 
disease_progression 
H-positive risk:  681 708 112 1080 421 97 1087 388 151 68 153 54 
H-negative risk:  708 681 1087 1080 388 421 97 112 153 151 54 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
237 
disease_progression 
H-positive risk:  671 710 111 1073 418 96 1103 387 156 68 155 52 
H-negative risk:  710 671 1103 1073 387 418 96 111 155 156 52 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
238 
disease_progression 
H-positive risk:  672 710 110 1068 423 97 1093 395 152 69 156 55 
H-negative risk:  710 672 1093 1068 395 423 97 110 156 152 55 69 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
239 
disease_progression 
H-positive risk:  669 714 112 1059 429 98 1092 397 151 70 154 55 
H-negative risk:  714 669 1092 1059 397 429 98 112 154 151 55 70 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
240 
disease_progression 
H-positive risk:  669 715 108 1057 435 97 1098 400 147 68 152 54 
H-negative risk:  715 669 1098 1057 400 435 97 108 152 147 54 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  658 721 108 1058 437 95 1093 411 148 67 147 57 
H-negative risk:  721 658 1093 1058 411 437 95 108 147 148 57 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
87 new agents 
242 
disease_progression 
H-positive risk:  661 725 112 1063 430 91 1090 408 154 67 145 54 
H-negative risk:  725 661 1090 1063 408 430 91 112 145 154 54 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
94 new agents 
243 
disease_progression 
H-positive risk:  666 730 116 1067 421 92 1082 409 153 66 146 52 
H-negative risk:  730 666 1082 1067 409 421 92 116 146 153 52 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
93 new agents 
244 
disease_progression 
H-positive risk:  656 734 117 1083 410 89 1087 410 153 65 142 54 
H-negative risk:  734 656 1087 1083 410 410 89 117 142 153 54 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
245 
disease_progression 
H-positive risk:  659 738 119 1078 402 88 1081 422 151 66 141 55 
H-negative risk:  738 659 1081 1078 422 402 88 119 141 151 55 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
246 
disease_progression 
H-positive risk:  663 734 118 1083 401 89 1081 418 149 64 145 55 
H-negative risk:  734 663 1081 1083 418 401 89 118 145 149 55 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
247 
disease_progression 
H-positive risk:  662 743 117 1083 395 89 1076 418 151 64 145 57 
H-negative risk:  743 662 1076 1083 418 395 89 117 145 151 57 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
248 
disease_progression 
H-positive risk:  663 745 116 1075 405 90 1078 415 149 64 143 57 
H-negative risk:  745 663 1078 1075 415 405 90 116 143 149 57 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
249 
disease_progression 
H-positive risk:  658 752 114 1074 403 91 1077 415 147 63 146 60 
H-negative risk:  752 658 1077 1074 415 403 91 114 146 147 60 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
250 
disease_progression 
H-positive risk:  654 746 111 1083 400 91 1078 420 146 64 147 60 
H-negative risk:  746 654 1078 1083 420 400 91 111 147 146 60 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
251 
disease_progression 
H-positive risk:  657 749 110 1078 404 90 1083 418 138 67 144 62 
H-negative risk:  749 657 1083 1078 418 404 90 110 144 138 62 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
252 
disease_progression 
H-positive risk:  659 745 110 1083 403 90 1083 417 136 68 144 62 
H-negative risk:  745 659 1083 1083 417 403 90 110 144 136 62 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
253 
disease_progression 
H-positive risk:  666 749 107 1083 398 92 1089 409 135 65 146 61 
H-negative risk:  749 666 1089 1083 409 398 92 107 146 135 61 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
254 
disease_progression 
H-positive risk:  665 754 108 1071 401 95 1079 418 137 64 145 63 
H-negative risk:  754 665 1079 1071 418 401 95 108 145 137 63 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
255 
disease_progression 
H-positive risk:  672 749 106 1078 395 94 1073 418 140 63 148 64 
H-negative risk:  749 672 1073 1078 418 395 94 106 148 140 64 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
256 
disease_progression 
H-positive risk:  672 754 105 1074 395 93 1063 428 142 63 146 65 
H-negative risk:  754 672 1063 1074 428 395 93 105 146 142 65 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
257 
disease_progression 
H-positive risk:  673 755 102 1073 390 93 1061 434 140 65 150 64 
H-negative risk:  755 673 1061 1073 434 390 93 102 150 140 64 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
258 
disease_progression 
H-positive risk:  675 759 102 1061 389 90 1056 442 143 64 153 66 
H-negative risk:  759 675 1056 1061 442 389 90 102 153 143 66 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  678 753 104 1051 393 92 1058 442 142 65 155 67 
H-negative risk:  753 678 1058 1051 442 393 92 104 155 142 67 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
260 
disease_progression 
H-positive risk:  675 749 105 1055 397 94 1061 435 140 65 159 65 
H-negative risk:  749 675 1061 1055 435 397 94 105 159 140 65 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
261 
disease_progression 
H-positive risk:  672 756 103 1050 398 94 1062 436 138 66 158 67 
H-negative risk:  756 672 1062 1050 436 398 94 103 158 138 67 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
262 
disease_progression 
H-positive risk:  669 755 104 1040 401 93 1073 434 137 67 159 68 
H-negative risk:  755 669 1073 1040 434 401 93 104 159 137 68 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
263 
disease_progression 
H-positive risk:  664 755 106 1046 399 94 1075 433 138 65 160 65 
H-negative risk:  755 664 1075 1046 433 399 94 106 160 138 65 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
264 
disease_progression 
H-positive risk:  664 753 103 1057 402 94 1073 425 138 64 161 66 
H-negative risk:  753 664 1073 1057 425 402 94 103 161 138 66 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
265 
disease_progression 
H-positive risk:  667 753 105 1059 406 96 1069 416 141 61 163 64 
H-negative risk:  753 667 1069 1059 416 406 96 105 163 141 64 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
266 
disease_progression 
H-positive risk:  669 745 107 1059 416 95 1068 413 144 59 162 63 
H-negative risk:  745 669 1068 1059 413 416 95 107 162 144 63 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
267 
disease_progression 
H-positive risk:  675 739 109 1054 415 96 1061 419 144 61 163 64 
H-negative risk:  739 675 1061 1054 419 415 96 109 163 144 64 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
268 
disease_progression 
H-positive risk:  678 743 103 1041 417 96 1067 422 144 60 165 64 
H-negative risk:  743 678 1067 1041 422 417 96 103 165 144 64 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
269 
disease_progression 
H-positive risk:  677 747 102 1034 420 97 1071 423 146 58 162 63 
H-negative risk:  747 677 1071 1034 423 420 97 102 162 146 63 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
270 
disease_progression 
H-positive risk:  676 743 103 1032 420 98 1074 424 149 60 159 62 
H-negative risk:  743 676 1074 1032 424 420 98 103 159 149 62 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
271 
disease_progression 
H-positive risk:  678 740 101 1029 430 101 1069 425 148 61 161 57 
H-negative risk:  740 678 1069 1029 425 430 101 101 161 148 57 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
272 
disease_progression 
H-positive risk:  678 737 100 1029 435 99 1069 423 151 62 160 57 
H-negative risk:  737 678 1069 1029 423 435 99 100 160 151 57 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
273 
disease_progression 
H-positive risk:  673 738 99 1036 433 99 1076 420 150 60 159 57 
H-negative risk:  738 673 1076 1036 420 433 99 99 159 150 57 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
274 
disease_progression 
H-positive risk:  671 736 100 1024 439 100 1085 420 151 58 159 57 
H-negative risk:  736 671 1085 1024 420 439 100 100 159 151 57 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
275 
disease_progression 
H-positive risk:  668 748 98 1025 435 101 1079 417 154 58 160 57 
H-negative risk:  748 668 1079 1025 417 435 101 98 160 154 57 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
276 
disease_progression 
H-positive risk:  672 745 97 1026 434 102 1074 418 155 60 158 59 
H-negative risk:  745 672 1074 1026 418 434 102 97 158 155 59 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
277 
disease_progression 
H-positive risk:  668 742 97 1027 440 102 1081 417 156 57 152 61 
H-negative risk:  742 668 1081 1027 417 440 102 97 152 156 61 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
278 
disease_progression 
H-positive risk:  673 734 94 1033 441 103 1080 417 155 55 156 59 
H-negative risk:  734 673 1080 1033 417 441 103 94 156 155 59 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
279 
disease_progression 
H-positive risk:  674 736 90 1034 440 102 1088 412 156 56 157 55 
H-negative risk:  736 674 1088 1034 412 440 102 90 157 156 55 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
280 
disease_progression 
H-positive risk:  674 739 91 1035 441 101 1088 406 155 57 159 54 
H-negative risk:  739 674 1088 1035 406 441 101 91 159 155 54 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
281 
disease_progression 
H-positive risk:  665 737 89 1044 437 101 1095 405 154 56 164 53 
H-negative risk:  737 665 1095 1044 405 437 101 89 164 154 53 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
282 
disease_progression 
H-positive risk:  666 729 89 1052 444 101 1093 400 153 56 164 53 
H-negative risk:  729 666 1093 1052 400 444 101 89 164 153 53 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
283 
disease_progression 
H-positive risk:  669 719 87 1052 449 101 1094 404 154 54 167 50 
H-negative risk:  719 669 1094 1052 404 449 101 87 167 154 50 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
284 
disease_progression 
H-positive risk:  667 716 88 1057 447 101 1090 404 161 53 168 48 
H-negative risk:  716 667 1090 1057 404 447 101 88 168 161 48 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
285 
disease_progression 
H-positive risk:  669 727 90 1060 449 101 1078 396 162 51 168 49 
H-negative risk:  727 669 1078 1060 396 449 101 90 168 162 49 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
286 
disease_progression 
H-positive risk:  665 728 92 1056 451 104 1076 400 163 49 167 49 
H-negative risk:  728 665 1076 1056 400 451 104 92 167 163 49 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
287 
disease_progression 
H-positive risk:  662 734 91 1054 448 105 1074 408 164 47 167 46 
H-negative risk:  734 662 1074 1054 408 448 105 91 167 164 46 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
288 
disease_progression 
H-positive risk:  659 715 95 1061 454 102 1069 419 168 47 166 45 
H-negative risk:  715 659 1069 1061 419 454 102 95 166 168 45 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
289 
disease_progression 
H-positive risk:  655 713 95 1058 448 106 1070 428 171 46 165 45 
H-negative risk:  713 655 1070 1058 428 448 106 95 165 171 45 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
290 
disease_progression 
H-positive risk:  658 713 93 1054 447 105 1078 422 175 45 167 43 
H-negative risk:  713 658 1078 1054 422 447 105 93 167 175 43 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
291 
disease_progression 
H-positive risk:  659 710 92 1058 444 102 1081 424 175 45 167 43 
H-negative risk:  710 659 1081 1058 424 444 102 92 167 175 43 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
292 
disease_progression 
H-positive risk:  670 707 92 1054 442 103 1081 426 169 49 163 44 
H-negative risk:  707 670 1081 1054 426 442 103 92 163 169 44 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
293 
disease_progression 
H-positive risk:  670 714 90 1062 442 102 1071 422 171 51 162 43 
H-negative risk:  714 670 1071 1062 422 442 102 90 162 171 43 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
294 
disease_progression 
H-positive risk:  677 725 90 1052 441 101 1069 419 171 50 161 44 
H-negative risk:  725 677 1069 1052 419 441 101 90 161 171 44 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
295 
disease_progression 
H-positive risk:  674 717 89 1060 443 99 1073 419 172 51 162 41 
H-negative risk:  717 674 1073 1060 419 443 99 89 162 172 41 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
296 
disease_progression 
H-positive risk:  678 712 88 1069 444 98 1077 406 167 56 165 40 
H-negative risk:  712 678 1077 1069 406 444 98 88 165 167 40 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
297 
disease_progression 
H-positive risk:  676 713 90 1074 446 98 1075 406 166 55 162 39 
H-negative risk:  713 676 1075 1074 406 446 98 90 162 166 39 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
298 
disease_progression 
H-positive risk:  672 714 89 1083 446 97 1069 405 164 55 166 40 
H-negative risk:  714 672 1069 1083 405 446 97 89 166 164 40 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
299 
disease_progression 
H-positive risk:  665 717 93 1086 443 95 1076 399 164 54 166 42 
H-negative risk:  717 665 1076 1086 399 443 95 93 166 164 42 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
300 
disease_progression 
H-positive risk:  664 718 93 1088 444 95 1074 403 165 52 161 43 
H-negative risk:  718 664 1074 1088 403 444 95 93 161 165 43 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
301 
disease_progression 
H-positive risk:  665 714 93 1092 444 94 1079 399 165 52 161 42 
H-negative risk:  714 665 1079 1092 399 444 94 93 161 165 42 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
105 new agents 
302 
disease_progression 
H-positive risk:  671 716 95 1091 441 97 1084 386 164 51 163 41 
H-negative risk:  716 671 1084 1091 386 441 97 95 163 164 41 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
303 
disease_progression 
H-positive risk:  675 716 95 1090 433 96 1080 390 165 56 162 42 
H-negative risk:  716 675 1080 1090 390 433 96 95 162 165 42 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
304 
disease_progression 
H-positive risk:  670 720 93 1092 438 94 1088 378 167 56 164 40 
H-negative risk:  720 670 1088 1092 378 438 94 93 164 167 40 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
305 
disease_progression 
H-positive risk:  672 726 94 1087 430 90 1101 376 173 52 162 37 
H-negative risk:  726 672 1101 1087 376 430 90 94 162 173 37 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
306 
disease_progression 
H-positive risk:  676 729 97 1089 416 88 1095 376 178 55 164 37 
H-negative risk:  729 676 1095 1089 376 416 88 97 164 178 37 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
307 
disease_progression 
H-positive risk:  676 730 97 1087 417 85 1102 373 178 55 164 36 
H-negative risk:  730 676 1102 1087 373 417 85 97 164 178 36 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
308 
disease_progression 
H-positive risk:  682 729 97 1079 419 85 1095 377 180 54 165 38 
H-negative risk:  729 682 1095 1079 377 419 85 97 165 180 38 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
309 
disease_progression 
H-positive risk:  680 727 97 1091 412 85 1102 373 176 54 163 40 
H-negative risk:  727 680 1102 1091 373 412 85 97 163 176 40 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
310 
disease_progression 
H-positive risk:  678 721 98 1090 412 88 1104 375 171 56 164 43 
H-negative risk:  721 678 1104 1090 375 412 88 98 164 171 43 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
311 
disease_progression 
H-positive risk:  677 714 97 1102 410 88 1103 371 172 58 164 44 
H-negative risk:  714 677 1103 1102 371 410 88 97 164 172 44 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
91 new agents 
312 
disease_progression 
H-positive risk:  679 719 96 1093 421 89 1097 371 169 54 165 47 
H-negative risk:  719 679 1097 1093 371 421 89 96 165 169 47 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
313 
disease_progression 
H-positive risk:  674 722 97 1093 415 90 1106 367 170 53 165 48 
H-negative risk:  722 674 1106 1093 367 415 90 97 165 170 48 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
314 
disease_progression 
H-positive risk:  682 711 95 1090 418 92 1105 366 170 55 169 47 
H-negative risk:  711 682 1105 1090 366 418 92 95 169 170 47 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
315 
disease_progression 
H-positive risk:  690 714 95 1090 417 91 1098 369 166 57 168 45 
H-negative risk:  714 690 1098 1090 369 417 91 95 168 166 45 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
316 
disease_progression 
H-positive risk:  690 717 96 1091 418 91 1096 367 162 60 167 45 
H-negative risk:  717 690 1096 1091 367 418 91 96 167 162 45 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
317 
disease_progression 
H-positive risk:  687 710 95 1095 420 87 1103 358 169 63 167 46 
H-negative risk:  710 687 1103 1095 358 420 87 95 167 169 46 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
318 
disease_progression 
H-positive risk:  690 704 97 1095 418 85 1107 358 172 64 165 45 
H-negative risk:  704 690 1107 1095 358 418 85 97 165 172 45 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
319 
disease_progression 
H-positive risk:  690 705 96 1095 416 86 1115 352 175 64 165 41 
H-negative risk:  705 690 1115 1095 352 416 86 96 165 175 41 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
320 
disease_progression 
H-positive risk:  690 704 96 1097 415 88 1119 344 177 65 166 39 
H-negative risk:  704 690 1119 1097 344 415 88 96 166 177 39 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
321 
disease_progression 
H-positive risk:  692 711 94 1099 411 88 1113 344 177 62 168 41 
H-negative risk:  711 692 1113 1099 344 411 88 94 168 177 41 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
322 
disease_progression 
H-positive risk:  705 705 93 1096 400 89 1105 352 182 59 172 42 
H-negative risk:  705 705 1105 1096 352 400 89 93 172 182 42 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
323 
disease_progression 
H-positive risk:  703 701 94 1101 399 87 1114 347 182 59 170 43 
H-negative risk:  701 703 1114 1101 347 399 87 94 170 182 43 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
324 
disease_progression 
H-positive risk:  697 709 92 1099 401 88 1118 349 179 57 167 44 
H-negative risk:  709 697 1118 1099 349 401 88 92 167 179 44 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
325 
disease_progression 
H-positive risk:  695 709 91 1098 405 86 1111 356 181 57 168 43 
H-negative risk:  709 695 1111 1098 356 405 86 91 168 181 43 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
326 
disease_progression 
H-positive risk:  697 709 90 1106 403 84 1103 360 178 59 168 43 
H-negative risk:  709 697 1103 1106 360 403 84 90 168 178 43 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
327 
disease_progression 
H-positive risk:  695 703 91 1117 403 82 1094 362 181 62 163 47 
H-negative risk:  703 695 1094 1117 362 403 82 91 163 181 47 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
328 
disease_progression 
H-positive risk:  698 705 90 1104 410 85 1097 364 179 63 164 41 
H-negative risk:  705 698 1097 1104 364 410 85 90 164 179 41 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
329 
disease_progression 
H-positive risk:  704 703 89 1110 401 82 1099 371 178 59 163 41 
H-negative risk:  703 704 1099 1110 371 401 82 89 163 178 41 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
330 
disease_progression 
H-positive risk:  702 694 89 1106 405 83 1100 378 176 59 166 42 
H-negative risk:  694 702 1100 1106 378 405 83 89 166 176 42 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
331 
disease_progression 
H-positive risk:  706 696 88 1104 405 82 1103 371 178 59 167 41 
H-negative risk:  696 706 1103 1104 371 405 82 88 167 178 41 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
332 
disease_progression 
H-positive risk:  709 696 90 1103 404 78 1100 374 182 58 165 41 
H-negative risk:  696 709 1100 1103 374 404 78 90 165 182 41 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
333 
disease_progression 
H-positive risk:  704 694 90 1109 402 77 1105 373 181 59 161 45 
H-negative risk:  694 704 1105 1109 373 402 77 90 161 181 45 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
334 
disease_progression 
H-positive risk:  703 696 92 1110 394 75 1116 374 180 56 162 42 
H-negative risk:  696 703 1116 1110 374 394 75 92 162 180 42 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
335 
disease_progression 
H-positive risk:  705 697 91 1114 402 78 1096 377 178 57 163 42 
H-negative risk:  697 705 1096 1114 377 402 78 91 163 178 42 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
336 
disease_progression 
H-positive risk:  709 692 92 1112 413 74 1089 377 181 57 164 40 
H-negative risk:  692 709 1089 1112 377 413 74 92 164 181 40 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
94 new agents 
337 
disease_progression 
H-positive risk:  703 700 92 1121 410 76 1092 367 180 55 165 39 
H-negative risk:  700 703 1092 1121 367 410 76 92 165 180 39 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
338 
disease_progression 
H-positive risk:  690 702 90 1122 413 74 1100 361 184 57 167 40 
H-negative risk:  702 690 1100 1122 361 413 74 90 167 184 40 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
339 
disease_progression 
H-positive risk:  679 707 88 1120 409 74 1101 374 182 60 163 43 
H-negative risk:  707 679 1101 1120 374 409 74 88 163 182 43 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
340 
disease_progression 
H-positive risk:  678 704 88 1124 410 74 1100 377 182 60 160 43 
H-negative risk:  704 678 1100 1124 377 410 74 88 160 182 43 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
341 
disease_progression 
H-positive risk:  681 706 89 1125 410 74 1087 385 179 62 157 45 
H-negative risk:  706 681 1087 1125 385 410 74 89 157 179 45 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
342 
disease_progression 
H-positive risk:  685 716 88 1117 413 77 1078 384 177 65 157 43 
H-negative risk:  716 685 1078 1117 384 413 77 88 157 177 43 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
343 
disease_progression 
H-positive risk:  680 717 88 1126 417 75 1067 384 177 64 161 44 
H-negative risk:  717 680 1067 1126 384 417 75 88 161 177 44 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
54 new agents 
344 
disease_progression 
H-positive risk:  680 711 89 1131 416 76 1064 388 175 64 162 44 
H-negative risk:  711 680 1064 1131 388 416 76 89 162 175 44 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
345 
disease_progression 
H-positive risk:  695 711 89 1130 410 76 1053 393 172 64 162 45 
H-negative risk:  711 695 1053 1130 393 410 76 89 162 172 45 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
346 
disease_progression 
H-positive risk:  696 714 87 1129 412 75 1057 395 171 60 161 43 
H-negative risk:  714 696 1057 1129 395 412 75 87 161 171 43 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
347 
disease_progression 
H-positive risk:  684 714 85 1137 412 75 1063 397 170 60 158 45 
H-negative risk:  714 684 1063 1137 397 412 75 85 158 170 45 60 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
348 
disease_progression 
H-positive risk:  676 718 85 1135 420 76 1065 389 173 59 160 44 
H-negative risk:  718 676 1065 1135 389 420 76 85 160 173 44 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
101 new agents 
349 
disease_progression 
H-positive risk:  684 729 88 1132 423 74 1059 380 172 58 160 41 
H-negative risk:  729 684 1059 1132 380 423 74 88 160 172 41 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
90 new agents 
350 
disease_progression 
H-positive risk:  684 722 86 1146 418 72 1058 380 172 60 161 41 
H-negative risk:  722 684 1058 1146 380 418 72 86 161 172 41 60 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 95 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
351 
disease_progression 
H-positive risk:  683 712 87 1146 422 77 1059 382 169 63 157 43 
H-negative risk:  712 683 1059 1146 382 422 77 87 157 169 43 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
352 
disease_progression 
H-positive risk:  686 710 85 1150 426 75 1050 387 168 61 161 41 
H-negative risk:  710 686 1050 1150 387 426 75 85 161 168 41 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
353 
disease_progression 
H-positive risk:  681 704 85 1152 426 77 1051 387 172 59 161 45 
H-negative risk:  704 681 1051 1152 387 426 77 85 161 172 45 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
354 
disease_progression 
H-positive risk:  687 696 80 1160 419 75 1051 394 170 57 166 45 
H-negative risk:  696 687 1051 1160 394 419 75 80 166 170 45 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
355 
disease_progression 
H-positive risk:  691 703 82 1151 418 74 1046 391 169 61 168 46 
H-negative risk:  703 691 1046 1151 391 418 74 82 168 169 46 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
356 
disease_progression 
H-positive risk:  687 703 80 1158 412 74 1042 392 170 63 174 45 
H-negative risk:  703 687 1042 1158 392 412 74 80 174 170 45 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
357 
disease_progression 
H-positive risk:  683 703 79 1153 414 74 1042 400 167 69 169 47 
H-negative risk:  703 683 1042 1153 400 414 74 79 169 167 47 69 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
358 
disease_progression 
H-positive risk:  689 706 79 1145 417 75 1038 397 166 69 168 51 
H-negative risk:  706 689 1038 1145 397 417 75 79 168 166 51 69 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
359 
disease_progression 
H-positive risk:  685 715 77 1133 416 77 1054 391 167 69 165 51 
H-negative risk:  715 685 1054 1133 391 416 77 77 165 167 51 69 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
360 
disease_progression 
H-positive risk:  680 716 78 1136 409 76 1067 390 168 66 165 49 
H-negative risk:  716 680 1067 1136 390 409 76 78 165 168 49 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
96 new agents 
Time difference of 15.3354 mins
This is task 29
